Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 23, 2000

View Archived Issues

Medigene, Aventis Enter Tumor Vaccine Deal Worth Up To $34M

Biovector, BioChem Pharma Align For Bacterium Vaccine

Epidauros Reports Discovery Of MDR-1 Gene Polymorphisms

Gemini Joins Genetics Effort Through Venture In Canada

CMV Research Shows NK Cells Have Role Controlling Infection

Chemunex Sees Further Gains In Acceptance Of ChemScan

MorphoSys, GPC Hit Milestone In Cancer Antibodies Program

Marketing Of Novartis' Bt Corn Blocked By German Authorities

New Debate Produces Further Delay In Framework For GMOs

Inpharmatica Identifies Target In Collaboration With Arrow

Israeli, Palestinian Scientists Unite For Research, Peace

Bavarian Nordic Moves Third Product Into Clinical Studies

Other News To Note

BTG Wins Israeli Approval For Recombinant Vaccine

Oxford Biomedica Signs 3rd Deal For Vector Technology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...